A therapeutic DNA vaccination strategy for autoimmunity and transplantation

Vaccine

Volumn 28, Issue 8, 2010, Pages 1897-1904

  Li, Alice ^a   Chen, Jianfeng ^a   Hattori, Masahiro ^a   Franco, Edson ^a,b   Zuppan, Craig ^a   Ojogho, Okechukwu ^a,b   Iwaki, Yuichi ^a   Escher, Alan ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Autoimmunity; DNA vaccine; Transplantation

Indexed keywords

COMPLEMENTARY DNA; CPG OLIGODEOXYNUCLEOTIDE; DNA VACCINE; GLUTAMATE DECARBOXYLASE; PLASMID DNA; PROTEIN BAX; RECOMBINANT ENZYME;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DNA IMMUNIZATION; DNA METHYLATION; FEMALE; GENE AMPLIFICATION; GRAFT REJECTION; GRAFT SURVIVAL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN; SKIN ALLOGRAFT; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; BCL-2-ASSOCIATED X PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CPG ISLANDS; DIABETES MELLITUS, TYPE 1; DNA METHYLATION; FEMALE; GLUTAMATE DECARBOXYLASE; GRAFT REJECTION; GRAFT SURVIVAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED NOD; PEPTIDE FRAGMENTS; PLASMIDS; SKIN TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; VACCINES, DNA;

EID: 76949097361     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.10.090     Document Type: Article

References (43)

1. Game D.S., and Lechler R.I. Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10 (2002) 101-108
2. Benichou G., Alessandrini A., Charrad R.S., and Wilkes D.S. Induction of autoimmunity after allotransplantation. Front Biosci 12 (2007) 4362-4369
3. Fedoseyeva E.V., Tam R.C., Popov I.A., Orr P.L., Garovoy M.R., and Benichou G. Induction of T cell responses to a self-antigen following allotransplantation. Transplantation 61 (1996) 679-683
4. Boros O., and Bromberg J.S. De novo autoimmunity after organ transplantation: targets and possible pathways. Hum Immunol 69 (2008) 383-388
5. Tantravahi J., Womer K.L., and Kaplan B. Why hasn't eliminating acute rejection improved graft survival?. Annu Rev Med 58 (2007) 369-385
6. + T cells in cardiac transplant patients. Transplantation 77 (2004) 1604-1609
7. Mi H., Carter V., Gupta A., Asher J., Shenton B.K., Stamp S., et al. Anti-vimentin antibody detection in recipients of heart-beating and non-heart beating donor kidneys. Transpl Proc 37 (2005) 3269-3271
8. Mahesh B., Leong H.S., McCormack A., Sarathchandra P., Holder A., and Rose M.L. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol 170 (2007) 1415-1427
9. Fedoseyeva E.V., Zhang F., Orr P.L., Levin D., Buncke H.J., and Benichou G. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 162 (1999) 6836-6842
10. Burlingham W.J., Love R.B., Jankowska-Gan E., Haynes L.D., Xu Q., Bobadilla J.L., et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117 (2007) 3498-3506
11. Iwata T., Philipovskiy A., Fisher A.J., Presson Jr. R.G., Chiyo M., Lee J., et al. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 181 (2008) 5738-5747
12. Duquesnoy R.J., Liu K., Fu X.F., Murase N., Ye Q., and Demetris A.J. Evidence for heat shock protein immunity in a rat cardiac allograft model of chronic rejection. Transplantation 67 (1999) 156-164
13. Caldas C., Luna E., Spadafora-Ferreira M., Porto G., Iwai L.K., Oshiro S.E., et al. Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses. Clin Exp Immunol 146 (2006) 66-75
14. Yasufuku K., Heidler K.M., O'Donnell P.W., Smith Jr. G.N., Cummings O.W., Foresman B.H., et al. Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 25 (2001) 26-34
15. Yasufuku K., Heidler K.M., Woods K.A., Smith Jr. G.N., Cummings O.W., Fujisawa T., et al. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 73 (2002) 500-505
16. Fedoseyeva E.V., Kishimoto K., Rolls H.K., Illigens B.M., Dong V.M., Valujskikh A., et al. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol 169 (2002) 1168-1174
17. Faulkner-Jones B.E., Cram D.S., Kun J., and Harrison L.C. Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat. Endocrinology 133 (1993) 2962-2972
18. Kono T., Nishimura F., Sugimoto H., Sikata K., Makino H., and Murayama Y. Human fibroblasts ubiquitously express glutamic acid decarboxylase 65 (GAD 65): possible effects of connective tissue inflammation on GAD antibody titer. J Periodontol 72 (2001) 598-604
19. Ito K., Tanaka K., Nishibe Y., Hasegawa J., and Ueno H. GABA-synthesizing enzyme, GAD67, from dermal fibroblasts: evidence for a new skin function. Biochim Biophys Acta 1770 (2007) 291-296
20. Valujskikh A., Fedoseyeva E., Benichou G., and Heeger P.S. Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation 73 (2002) 1130-1137
21. Li A.F., Hough J., Henderson D., and Escher A. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine 22 (2004) 1751-1763
22. + regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 322 (2007) 1-11
23. + regulatory T cells in vitro. Vaccine 24 (2006) 5036-5046
24. Komura J., Okada T., and Ono T. Repression of transient expression by DNA methylation in transcribed regions of reporter genes introduced into cultured human cells. Biochim Biophys Acta 1260 (1995) 73-78
25. Qu G.Z., and Ehrlich M. Demethylation and expression of methylated plasmid DNA stably transfected into HeLa cells. Nucleic Acids Res 27 (1999) 2332-2338
26. Pentcheva-Hoang T., Egen J.G., Wojnoonski K., and Allison J.P. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21 (2004) 401-413
27. Lohr J., Knoechel B., and Abbas A.K. Regulatory T cells in the periphery. Immunol Rev 12 (2006) 149-162
28. Suciu-Foca Cortesini N., Piazza F., Ho E., Ciubotariu R., LeMaoult J., Dalla-Favera R., et al. Distinct mRNA microarray profiles of tolerogenic dendritic cells. Hum Immunol 62 (2001) 1065-1072
29. Boruchov A.M., Heller G., Veri M.C., Bonvini E., Ravetch J.V., and Young J.W. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 115 (2005) 2914-2923
30. Bros M., Jährling F., Renzing A., Wiechmann N., Dang N.A., Sutter A., et al. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid. Blood 109 (2007) 3820-3829
31. Jenkins M.K., and Schwartz R.H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165 (1987) 302-319
32. Gao W., Lu Y., El Essawy B., Oukka M., Kuchroo V.K., and Strom T.B. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 7 (2007) 1722-1732
33. Joffre O., Santolaria T., Calise D., Al Saati T., Hudrisier D., Romagnoli P., et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14 (2008) 88-92
34. Gökmen M.R., Lombardi G., and Lechler R.I. The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol 20 (2008) 568-574
35. Birge R.B., and Ucker D.S. Innate apoptotic immunity: the calming touch of death. Cell Death Differ 15 (2008) 1096-1102
36. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 31 (2001) 3026-3037
37. Sasaki S., Amara R.R., Oran A.E., Smith J.M., and Robinson H.L. Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat Biotechnol 19 (2001) 543-547
38. Chattergoon M.A., Kim J.J., Yang J.S., Robinson T.M., Lee D.J., Dentchev T., et al. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nat Biotechnol 18 (2000) 974-979
39. Pendl G.G., Robert C., Steinert M., Thanos R., Eytner R., Borges E., et al. Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. Blood 99 (2002) 946-956
40. Kleinclauss F., Perruche S., Masson E., de Carvalho Bittencourt M., Biichle S., Remy-Martin J.P., et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 13 (2006) 41-52
41. Wang Z., Larregina A.T., Shufesky W.J., Perone M.J., Montecalvo A., Zahorchak A.F., et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transpl 6 (2006) 1297-1311
42. Wang Z., Shufesky W.J., Montecalvo A., Divito S.J., Larregina A.T., and Morelli A.E. In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS ONE 4 (2009) e4940
43. Mahnke K., Johnson T.S., Ring S., and Enk A.H. Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. J Dermatol Sci 46 (2007) 159-167